34 related articles for article (PubMed ID: 33317841)
1. A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066.
De Fusco C; Brear P; Iegre J; Georgiou KH; Sore HF; Hyvönen M; Spring DR
Bioorg Med Chem; 2017 Jul; 25(13):3471-3482. PubMed ID: 28495381
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase CK2 in health and disease: Structural bases of protein kinase CK2 inhibition.
Battistutta R
Cell Mol Life Sci; 2009 Jun; 66(11-12):1868-89. PubMed ID: 19387547
[TBL] [Abstract][Full Text] [Related]
3. Antitumoral activity of allosteric inhibitors of protein kinase CK2.
Moucadel V; Prudent R; Sautel CF; Teillet F; Barette C; Lafanechere L; Receveur-Brechot V; Cochet C
Oncotarget; 2011 Dec; 2(12):997-1010. PubMed ID: 22184283
[TBL] [Abstract][Full Text] [Related]
4. Structure of human protein kinase CK2 alpha 2 with a potent indazole-derivative inhibitor.
Nakaniwa T; Kinoshita T; Sekiguchi Y; Tada T; Nakanishi I; Kitaura K; Suzuki Y; Ohno H; Hirasawa A; Tsujimoto G
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Feb; 65(Pt 2):75-9. PubMed ID: 19193990
[TBL] [Abstract][Full Text] [Related]
5. Enhanced inhibitory activity of compounds containing purine scaffolds compared to protein kinase CK2α considering crystalline water.
Nishiwaki K; Nakatani S; Nakamura S; Yoshioka K; Nakagawa E; Tsuyuguchi M; Kinoshita T; Nakanishi I
RSC Med Chem; 2024 Apr; 15(4):1274-1282. PubMed ID: 38665825
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in the Discovery of CK2 Inhibitors.
Al-Qadhi MA; Yahya TAA; El-Nassan HB
ACS Omega; 2024 May; 9(19):20702-20719. PubMed ID: 38764653
[TBL] [Abstract][Full Text] [Related]
7. Exploring the potential of approved drugs for triple-negative breast cancer treatment by targeting casein kinase 2: Insights from computational studies.
Shoaib TH; Ibraheem W; Abdelrahman M; Osman W; Sherif AE; Ashour A; Ibrahim SRM; Ghazawi KF; Miski SF; Almadani SA; ALsiyud DF; Mohamed GA; Alzain AA
PLoS One; 2023; 18(8):e0289887. PubMed ID: 37578958
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of Novel Acyl Derivatives of 3-(4,5,6,7-Tetrabromo-1
Chojnacki K; Wińska P; Karatsai O; Koronkiewicz M; Milner-Krawczyk M; Wielechowska M; Rędowicz MJ; Bretner M; Borowiecki P
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200807
[TBL] [Abstract][Full Text] [Related]
9. Structure-guided discovery of adenosine triphosphate-competitive casein kinase 2 inhibitors.
Patel S; Vyas VK; Sharma M; Ghate M
Future Med Chem; 2023 Jun; 15(11):987-1014. PubMed ID: 37307219
[TBL] [Abstract][Full Text] [Related]
10. Tetrabromobenzotriazole (TBBt) and tetrabromobenzimidazole (TBBz) as selective inhibitors of protein kinase CK2: evaluation of their effects on cells and different molecular forms of human CK2.
Zien P; Duncan JS; Skierski J; Bretner M; Litchfield DW; Shugar D
Biochim Biophys Acta; 2005 Dec; 1754(1-2):271-80. PubMed ID: 16203192
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological properties and structural study of new halogenated azolo[4,5-b]pyridines as inhibitors of CK2 kinase.
Chojnacki K; Lindenblatt D; Wińska P; Wielechowska M; Toelzer C; Niefind K; Bretner M
Bioorg Chem; 2021 Jan; 106():104502. PubMed ID: 33317841
[TBL] [Abstract][Full Text] [Related]
12. Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases.
Chojnacki K; Wińska P; Wielechowska M; Łukowska-Chojnacka E; Tölzer C; Niefind K; Bretner M
Bioorg Chem; 2018 Oct; 80():266-275. PubMed ID: 29966873
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro antiproliferative activity and kinase profile of new benzimidazole and benzotriazole derivatives.
Chojnacki K; Wińska P; Skierka K; Wielechowska M; Bretner M
Bioorg Chem; 2017 Jun; 72():1-10. PubMed ID: 28340404
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel chiral TBBt derivatives with hydroxyl moiety. Studies on inhibition of human protein kinase CK2α and cytotoxicity properties.
Borowiecki P; Wawro AM; Wińska P; Wielechowska M; Bretner M
Eur J Med Chem; 2014 Sep; 84():364-74. PubMed ID: 25036794
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]